Ramjanee, S., Robertson, J., Franke-Fayard, B., Sinha, R., Waters, A., Janse, C., . . . Sinden, R. (2007). The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
Chicago Style (17th ed.) CitationRamjanee, S., et al. The Use of Transgenic Plasmodium Berghei Expressing the Plasmodium Vivax Antigen P25 to Determine the Transmission-blocking Activity of Sera from Malaria Vaccine Trials. 2007.
MLA (9th ed.) CitationRamjanee, S., et al. The Use of Transgenic Plasmodium Berghei Expressing the Plasmodium Vivax Antigen P25 to Determine the Transmission-blocking Activity of Sera from Malaria Vaccine Trials. 2007.
Warning: These citations may not always be 100% accurate.